医学
旁侵犯
肝内胆管癌
放化疗
单变量分析
内科学
外科
吉西他滨
多元分析
胃肠病学
放射治疗
肿瘤科
癌症
作者
Kyung Soo Kim,Hwi Young Kim,Kyubo Kim,Nam‐Joon Yi,Kyung‐Suk Suh,Eui Kyu Chie
标识
DOI:10.17998/jlc.18.2.115
摘要
Background/Aims: To investigative the potential role of postoperative chemoradiotherapy (CCRT) after R1 resection of intrahepatic cholangiocarcinoma (IHCC).Methods: Between January 2000 and December 2012, medical records of 18 patients who underwent curative surgery with R1 resection for IHCC were retrospectively reviewed.Results: Median age was 68 years and 12 patients (66.7%) were male.Median tumor size was 5.0 cm (range, 2.2-11.0)and 12 patients (66.7%) had T3 or higher disease.Lymph nodes were involved in four patients (22.2%).Vascular invasion and perineural invasion were present in 10 (55.6%) and 12 patients (66.7%), respectively.Postoperative CCRT given with 5-fluorouracil or gemcitabine were delivered to 7 patients (38.9%).Median radiation dose was 50.4 Gy (range, 45-54).Univariate analysis showed that median loco-regional recurrence-free survival (LRRFS), progression-free survival (PFS) and overall survival (OS) were prolonged for patients treated with CCRT (median LRRFS; 5.6 months vs. not reached, P<0.001, median PFS; 5.6 vs. 8.3 months, P=0.047, median OS; 15.0 vs. 26.6 months, P=0.064).Conclusions: Postoperative CCRT improved the loco-regional control and PFS in IHCC patients with R1 resection.Further study is warranted to validate the role of postoperative CCRT for these patients.(
科研通智能强力驱动
Strongly Powered by AbleSci AI